Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Long-Term Debt Issuances (2016 - 2019)

Historic Long-Term Debt Issuances for ENDRA Life Sciences (NDRA) over the last 4 years, with Q3 2019 value amounting to $2.5 million.

  • ENDRA Life Sciences' Long-Term Debt Issuances changed N/A to $2.5 million in Q3 2019 from the same period last year, while for Dec 2020 it was $2.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.5 million for FY2019, which is 16627.83% up from last year.
  • As of Q3 2019, ENDRA Life Sciences' Long-Term Debt Issuances stood at $2.5 million.
  • In the past 5 years, ENDRA Life Sciences' Long-Term Debt Issuances registered a high of $2.5 million during Q3 2019, and its lowest value of -$132000.0 during Q4 2016.
  • Moreover, its 4-year median value for Long-Term Debt Issuances was $225000.0 (2017), whereas its average is $700749.9.
  • Data for ENDRA Life Sciences' Long-Term Debt Issuances shows a peak YoY increase of 35000.0% (in 2017) and a maximum YoY decrease of 35000.0% (in 2017) over the last 5 years.
  • Over the past 4 years, ENDRA Life Sciences' Long-Term Debt Issuances (Quarter) stood at -$132000.0 in 2016, then skyrocketed by 270.45% to $225000.0 in 2017, then surged by 315.69% to $935300.0 in 2018, then surged by 166.28% to $2.5 million in 2019.
  • Its Long-Term Debt Issuances stands at $2.5 million for Q3 2019, versus $935300.0 for Q2 2018 and $225000.0 for Q1 2017.